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Cell death and the release of chromatin have been demonstrated to activate the immune system 
producing autoantibodies against nuclear antigens in patients with systemic lupus erythematosus 
(SLE). Apoptosis, necrosis, necroptosis, secondary necrosis, autophagy and the clearance of 
dying cells by phagocytosis are processes believed to have a role in tolerance avoidance, 
activation of autoimmune lymphocytes and tissue damage by effector cells. The released 
chromatin not only activates the immune system. It also acts as antigen for the produced 
autoantibodies including anti-dsDNA antibodies. The subsequent immune complex formation is 
deposited within the basement membranes and the mesangial matrix of glomeruli. This may be 
considered as an initiating event in lupus nephritis. The origin of the released chromatin is still 




Chromatin or nucleosomes are the driving antigens in the induction of anti-double-stranded 
(ds)DNA antibodies. The presence of anti-dsDNA antibodies is a hallmark of Systemic lupus 
erythematosus (SLE). The process is driven by special, autoimmune T helper (Th) cells specific 
to epitopes in various DNA-binding nucleoproteins such as histones [1;2]. Anti-dsDNA 
antibodies form immune complexes with nucleosomes that deposits within basement membranes 
in the body, eg skin and kidney, and may cause a systemic inflammation [3-6].  Lupus nephritis is 
characterized by the deposition of such immune complexes within the mesangial matrix and 
basement membranes of glomeruli, in addition to deposition within the basal membrane of the 
main renal arteries and micro-capillaries surrounding the tubuli [7]. The binding of anti-
dsDNA/nucleosomes immune complexes to basement membranes is mediated via nucleosomes. 
Nucleosomes show an  affinity towards membrane components [8;9]. We have previously 
demonstrated that the production of anti-dsDNA abs, formation of immune complexes and 
subsequent deposition precedes presence of infiltrating immune cells within the kidneys and the 
development of proteinuria of lupus prone mice [10]. The release of nucleosomal antigens may 
therefore play a crucial role in the initiation of lupus nephritis.  
Nucleosomes are complexes composed of dsDNA and histones. One nucleosome is 
composed of 180 basepairs of dsDNA and histone proteins organized as a protein octamer with 
the dsDNA wrapped in 1.65 turns of a superhelix [11]. An exterior linker histone stabilizes the 
structure together with a linker dsDNA connecting adjacent nucleosomes. Chromatin or 
nucleosomes contain protein complexes of DNA and histone binding proteins [12] and is 
normally located in the nucleus of the cell. Chromatin can be released during cell damage or 
death. However, mechanism like cell activation has also been shown to release nucleosomes in 
form of micro particles. The presence of nucleosomes has been detected in sera from normal 
individual and in patients with SLE [13]. In mice the levels of circulating nucleosomes decreases 
when anti-dsDNA antibody production increases during the progression of the disease, and may 
reflect formation and deposition of immune complexes [13]. Treatment with heparin prevented 
the deposition of immune complexes probably by making the nucleosomes more accessible for 
degradation by nucleases [14]. The main source of nucleosomes in SLE is believed to arrive from 
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dead cells of a apoptotic or necrotic origin. Possible mechanisms and cell sources of extracellular 
nucleosomes are discussed. 
 
Mechanisms of programmed cell death as the origin for release of nucleosomes and 
activation of autoimmune cells 
Apoptosis, or programmed cell death (PCD) is essential for embryonic development and renewal 
of tissue by eliminating cells that are abnormal and potentially dangerous [15]. PCD maintains 
homeostasis of the immune system, eg. after massive expansion of reactive T cells and B cells in 
response to infection [16]. This is important in order to sustain immune tolerance and is a key 
process in the positive and negative selection of B and T lymphocytes eliminating potential self-
reactive cells [17]. Apoptosis can be initiated by several death receptors on the cell surface or 
from signals within the cell in response to stress, DNA damage, defective cells cycle etc [15]. 
Apoptosis is characterized by activation of caspases, DNA fragmentation and membrane blebb 
formation [18]. Importantly, apoptosis does not normally activate the immune system, and 
apoptotic cells are cleared by phagocytes without the release of nucleosomes and with little 
consequent inflammation. However, nucleosomes are exposed at the cell surface of apoptotic 
blebs [19]. Inefficient clearance of dying cells may result in the accumulation of apoptotic cell 
remnants leading to a process called secondary necrosis [20]. This will lead to degeneration of 
the cell remnants and release of nucleosomes and other damage-associated molecular patterns 
(DAMPs) like HMGB1, IL-1a, uric acid, mitochondrial content, and ATP like those observed 
during necrosis or necroptosis (see below)[21]. Incomplete chromatin digestion by phagocytes 
may also lead to the release of particles containing nucleic acids [20]. Chromatin modifications 
such as acetylation and methylation of histones have been demonstrated during apoptosis 
(reviewed in [22]) and autoantibodies specific for acetylated and methylated histone epitopes 
have been found in SLE patients and in experimental mice [23;24]. Since the apoptotic process 
may modify the nucleic acids to look more like foreign antigen e.g.  a viral particle, the antigen 
presenting cells (APCs, dendritic cells and B cells) may take it up, recognize it as foreign and get 
activated [25]. Apoptotic blebs with chromatin modifications have been demonstrated to activate 
dendritic cells with subsequent IL-17 production of co-cultured T cells [26]. 
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In contrast to apoptosis, necrotic cell death is characterized by cellular organ and 
cytoplasma swelling which leads to rapture of the plasma membrane and subsequent cell lysis 
[27]. It was originally considered as a non-controlled death mechanism, but recent data has 
pointed at certain tightly controlled types of necrosis called necroptosis [28]. This process is 
dependent on the serine-threonine kinase RIP1 (RIPK1) and the RIP1 family member RIP3 has 
been identified as a key mediator of caspase-independent cell death [29]. The interplay between 
apoptosis and necroptosis is important for the elimination of excess T cells after an immune 
response [30]. Interestingly, the pro inflammatory cytokine tumor necrosis factor (TNF) can 
induce apoptosis in certain cell types and necrosis on others [31]. Many other signals of the 
immune system like ligation of Fas, engagement of toll like receptors (TLR) or TCR by dsDNA 
and anti-CD3 antibodies respectively, have been shown to trigger necroptosis [32]. The induction 
of necrosis or necroptosis by pro-inflammatory cytokines and other triggers may increase the 
release of nucleosomes. Necroptosis has not been investigated in SLE but extensive studies on 
tumour necrosis factor-like weak inducer of apoptosis (TWEAK) indicate a central role for the 
TNF pathways in the induction of lupus nephritis [33]. 
Authophagy is a third mechanism that could lead to PCD.Autophagy is an intra-cellular 
degradation system that allows the cells to consume itself for energy and is triggered by stress 
conditions like starvation or could be a part of normal turnover of cellular contents [34]. 
Autophagy has been shown to be involved in the elimination of microorganisms, control of pro-
inflammatory signaling, adaptive immunity and secretion of immune mediators (reviewed in 
[35]). Autophagy can rescue cells from the apoptotic process by interfering with the apoptotic 
signaling cascade. Inflammasome activation and secretion of immune mediators are regulated by 
autophagy through regulatory interactions with innate immune signaling pathways [35]. 
Autophagy has been demonstrated to be important in both T and B cell immunity by contributing 
to antigen presentation, T cell homeostasis and polarization, and to survival of mature B cells and 
required for plasmablast formation [35]. The impact of autophagy in SLE has recently been 
reviewed and shown to be activated [36]. Autophagy is increased in SLE patients and lupus prone 
mice [36]. It is involved in the survival of autoreactive B cells and required for the differentiation 
of plasmablasts [37]. An increased amount of autophagic compartments was observed in T cells 
from lupus prone mice and SLE patents, indicating a deregulation of autophagy in SLE [38].  
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In response to pathogens neutrophils may die in a process called NETosis [39]. Upon 
stimulation or engagement with pathogens neutrophils release extracellular traps (NETs) that 
consist of nucleosomes and neutrophil proteins. These may surround the pathogen and increase 
the likelihood of phagocytosis by macrophages [40]. NETs released by dying neutrophils are 
normally degraded by Dnase1 within the circulation [40]. Impaired degradation of NETs has 
been seen in sera from SLE patients and this was associated with lupus nephritis [41]. Recently 
published studies demonstrate that NETs can induce innate pDC activation through TLR9 and 
TLR7 [42;43]. Increased infiltration and activation of neutrophils within the kidney with 
subsequent release of NETs may be harmful in SLE. The NETs may be targeted by anti-dsDNA 
antibodies which may promote IC deposition within the mesangial matrix and GBM, therefore 
being a potentially crucial factor in development of lupus nephritis (see below).  
 
Dying cells as source of released chromatin in lupus nephritis 
Whether apoptotic kidney cells are the source of released renal chromatin is controversial. Some 
groups demonstrate increased apoptosis of residential kidneys cells [3;4;44;45], while others 
claim that there is no increase in apoptotic kidneys cells of lupus patients and in mouse models of 
lupus nephritis [46;47]. Looking at immune complex deposition there are several possible kidney 
cell types and infiltrating immune cells that may be a possible source of chromatin.  
 
Glomerular mesangial cells, endothelial cells, and podocytes 
The first deposition of immune complexes is observed within the glomerular mesangial matrix. It 
is therefore likely that the source of released chromatin may come from dying mesangial cells. 
One of the theories of anti-dsDNA ab deposition is the “planted antigen” theory [48]. Chromatin 
released from mesangial cells into the mesangial matrix or glomerular basement membrane may 
bind circulating anti-dsDNA ab and thereby form the immune complexes observed as electron 
dense structures  [48]. However, released chromatin without autoantibodies has never been 
observed in the mesangial matrix or the GMB of lupus prone mice or in biopsies of SLE patients.  
Immune complexes may be actively cleared by mesangial cells into the mesangial matrix [49]. 
Due to the affinity of nucleosomes towards the matrix components a consequent accumulation of 
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immune complexes are a more likely mechanism and may be named the “planted immune 
complex” theory. The immune complexes may activate the mesangial cells through FcRs or 
TLRs to produce cytokines and chemokines that will attract infiltrating cells [7](see below). We 
have recently demonstrated that nucleosomes alone can activate mesangial cells to produce 
cytokines and chemokines [50]. Other cells nearby like the glomerular endothelial cells and 
podocytes are believed to contribute to the subendothelial and subepithelial deposits observed 
within the GBM. This theory has never been proven, and we speculate that it is more likely that 
the subendothelial and subepithelial depositions is due to the pressure of the blood flow forcing 
the immune complexes more and more towards the epithelial side of the GMB were they are 
stopped against the podocytes.  
 
Tubular cells and microcapillary endothelial cells 
Other renal cells include the different tubular cells and the endothelial cells in arteries and 
capillaries within the renal circulation. Apoptosis of tubular cells has been detected in human 
kidney biopsies, but the levels were found to be too low to be considered as a reasonable 
quantitative source for autoantibody binding and immune complex formation [46]. The capillary 
endothelial cells are the most likely candidate for the source of released chromatin fragments of 
the residential kidney cells. They are in direct contact with the circulating anti-dsDNA 
antibodies/nucleosomes and the activated effector cells. Nucleosomes have been shown to 
activate endothelial cell to produce pro-inflammatory cytokines like IL6 and IL8 [51]. In addition 
endothelial bound nucleosomes and C1q are targets for autoantibodies and lead to activation of 
complement [52]. Endothelial cells are activated during inflammatory processes and may release 
microparticles containing chromatin fragments that bind anti-dsDNA antibodies [53;54]. Staining 
with anti-Meca32 and endoglin(CD105) antibodies on kidney sections of NZBWF1 mice 
revealed that immune complex deposits in the mesangial matrix contained Meca32 and endoglin 
(Figure 1) during different stages of the disease. Endoglin is known to be expressed on activated 
endothelial cells thereby explaining the staining within the glomeruli. Meca 32 is not expressed 
on glomerular endothelial cells. This may point at dead endothelial cells or released endothelial 
microparticles as a source of the chromatin found in immune complex depositions [55]. However, 
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the release of microparticles into the circulation is not restricted to the kidney and may origin 
from endothelial cells outside the kidneys. 
 
Infiltrating granulocytes, macrophages, T and B cells 
Polymorphonuclear leukocytes (granulocytes) are normally the first cells recruited at sites of 
inflammation [56]. Nucleosomes have been shown to induce activation and secretion of pro-
inflammatory cytokines by PMN [57]. Netting neutrophils have recently been demonstrated to 
induce endothelial damage, infiltrate tissue and expose immunological stimulatory molecules in 
SLE patients [58]. However, their role in lupus nephritis was not investigated [58]. Impairment in 
clearance of nets by reduced degradation is associated with proteinuria in lupus patients [41]. An 
imbalance in proapoptotic and antiapoptotic factors was shown in both neutrophils and sera from 
patients with juvenile-onset SLE, leading to increased neutrophil apoptosis in these patients [59]. 
Mice studies have not revealed the role of neutrophils as the mice have small amount of these 
cells in the circulation in comparison to humans [56]. However we found an increase in 
infiltrating granulocytes within the glomeruli and interstitial between tubuli in B/W mice with 
anti-dsDNA antibodies and proteinuric mice compared with young mice, although no indication 
that these cells are the origin of deposited chromatin [50].  
Macrophages are essential in the clearance of apoptotic cell debris and immune 
complexes. Studies have shown that induction of apoptosis in circulating macrophages by 
chlodronate filled liposomes accelerated the development of lupus nephritis in lupus prone mice 
[60]. This was possible due to a subsequent decrease in the clearance of apoptotic cells and 
thereby increasing the amount of circulating chromatin [60]. There are no known studies on the 
role of increased cell death of T cells in lupus nephritis. There are however an enormous amount 
of infiltrating T cells and macrophages within the kidney of lupus prone mice and SLE patients. 
The T cells infiltrating glomeruli in lupus prone mice are CD3+ T cells (Figure 1) of all classes, 
Th1, Th2 and Th17 cells [61]. The fate if these cells during the disease have not been 
investigated, but considering the amount and the life span of these helper and effector cells, they 
may be a source of released chromatin. Apoptosis of B cells have been demonstrated to 
accelerate lupus nephritis in lupus prone mice [62]. Studies of B cell infiltration has revealed that 
this happens only after immune complex deposition and is mainly located in tertiary lymphoid 
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structures within the kidney and not in glomeruli and interstitial between tubules. However, B 
cells are essential for driving the disease from silent mesangial nephritis to end stage disease [63]. 
 
Concluding hypothesis 
Production of anti-dsDNA ab, formation of immune complex, and their subsequent deposition 
within the mesangial matrix activate mesangial cells to produce cytokines and chemokines 
thereby attracting immune cells. Circulating immune complexes activate endothelial cells and 
may release chromatin containing microparticles that, if not properly cleared, may act as antigen 
for autoantibodies. This will contribute to the amount of immune complexes formed. The 
infiltration of effector cells accelerates the inflammation and tissue damage within the glomeruli 
and activate endothelial cells. This will recruit and maintain lymphocyte infiltration into the 
interstitium. Increase in inflammation will increase the amount of dying cells within the kidney 
whatever origin they have, and lead to excess amount of released chromatin that amplify the 
disease process. The exact mechanism(s) leading to breakage of tolerance and activation of 
autoantigen specific lymphocytes are still unknown. Novel strategies for the prevention of lupus 
nephritis may depend on the further investigations of programmed cell death and the role of 
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Figure 1. Glomerular detection of autologous cells as source of released chromatin. Kidney 
sections of lupus prone NZB/WF1 mice at different ages (4 and 34 w.o) were stained with anti-
Meca32, anti-endoglin (CD105), anti-F480 (all from BioLegend, San Diego, CA, USA), anti-CD3 
(Dako, Glostrup, Denmark ) antibodies detected by IHC using Polink-2 Plus HRP detection kits for 
tissue (Golden Bridge International, Inc, Mukilteo, WA, USA) according to protocol described in 
details in [50]. All pictures are taken at 400 x , scale bar= 50µm. 
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